[{"address1": "3891 Ranchero Drive", "address2": "Suite 150", "city": "Ann Arbor", "state": "MI", "zip": "48108", "country": "United States", "phone": "734 887 3903", "website": "https://www.esperion.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.", "fullTimeEmployees": 304, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sheldon L. Koenig M.B.A.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1262378, "exercisedValue": 0, "unexercisedValue": 18056}, {"maxAge": 1, "name": "Mr. Benjamin  Halladay M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 713958, "exercisedValue": 0, "unexercisedValue": 5625}, {"maxAge": 1, "name": "Mr. Benjamin O. Looker J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 696350, "exercisedValue": 0, "unexercisedValue": 4219}, {"maxAge": 1, "name": "Mr. Glenn P. Brame", "age": 67, "title": "Chief Technical Operations Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Tiffany  Aldrich M.B.A.", "title": "Associate Director of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betty Jean Swartz", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "LeAnne  Bloedon M.S.", "title": "VP & Head of Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John B. Harlow Jr.", "age": 49, "title": "Chief Commercial Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Pinkosky", "title": "Vice President of Drug Discovery of Early Pre-Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.95, "open": 3.93, "dayLow": 3.87, "dayHigh": 4.05, "regularMarketPreviousClose": 3.95, "regularMarketOpen": 3.93, "regularMarketDayLow": 3.87, "regularMarketDayHigh": 4.05, "payoutRatio": 0.0, "beta": 1.009, "forwardPE": 134.66667, "volume": 4531357, "regularMarketVolume": 4531357, "averageVolume": 6890267, "averageVolume10days": 6067750, "averageDailyVolume10Day": 6067750, "bid": 2.68, "ask": 4.0, "bidSize": 2, "askSize": 1, "marketCap": 957759680, "fiftyTwoWeekLow": 0.69, "fiftyTwoWeekHigh": 4.13, "allTimeHigh": 120.96, "allTimeLow": 0.69, "priceToSalesTrailing12Months": 3.1525788, "fiftyDayAverage": 3.264, "twoHundredDayAverage": 1.99775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1466297728, "profitMargins": -0.34835997, "floatShares": 234923762, "sharesOutstanding": 237069239, "sharesShort": 28827852, "sharesShortPriorMonth": 24958080, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.1216, "heldPercentInsiders": 0.00617, "heldPercentInstitutions": 0.47297, "shortRatio": 4.43, "shortPercentOfFloat": 0.1221, "impliedSharesOutstanding": 237069239, "bookValue": -2.197, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -105831000, "trailingEps": -0.54, "forwardEps": 0.03, "enterpriseToRevenue": 4.826, "enterpriseToEbitda": -50.089, "52WeekChange": 0.83720934, "SandP52WeekChange": 0.17354333, "quoteType": "EQUITY", "currentPrice": 4.04, "targetHighPrice": 16.0, "targetLowPrice": 1.72, "targetMeanPrice": 6.5025, "targetMedianPrice": 4.65, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 92447000, "totalCashPerShare": 0.39, "ebitda": -29274000, "totalDebt": 600985024, "quickRatio": 0.589, "currentRatio": 1.004, "totalRevenue": 303801984, "revenuePerShare": 1.538, "returnOnAssets": -0.05416, "grossProfits": 131898000, "freeCashflow": -78274248, "operatingCashflow": -93288000, "revenueGrowth": 0.691, "grossMargins": 0.43416, "ebitdaMargins": -0.09636, "operatingMargins": -0.11407, "financialCurrency": "USD", "symbol": "ESPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1372253400000, "corporateActions": [], "postMarketTime": 1766795462, "regularMarketTime": 1766782801, "shortName": "Esperion Therapeutics, Inc.", "longName": "Esperion Therapeutics, Inc.", "postMarketChangePercent": 0.0, "postMarketPrice": 4.04, "postMarketChange": 0.0, "regularMarketChange": 0.0899999, "regularMarketDayRange": "3.87 - 4.05", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 6890267, "fiftyTwoWeekLowChange": 3.35, "fiftyTwoWeekLowChangePercent": 4.8550725, "fiftyTwoWeekRange": "0.69 - 4.13", "fiftyTwoWeekHighChange": -0.09000015, "fiftyTwoWeekHighChangePercent": -0.021791805, "fiftyTwoWeekChangePercent": 83.72093, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762434000, "earningsCallTimestampEnd": 1762434000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.54, "epsForward": 0.03, "epsCurrentYear": -0.06714, "priceEpsCurrentYear": -60.172775, "fiftyDayAverageChange": 0.776, "fiftyDayAverageChangePercent": 0.2377451, "twoHundredDayAverageChange": 2.04225, "twoHundredDayAverageChangePercent": 1.022275, "priceToBook": -1.8388711, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_28236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.27848, "regularMarketPrice": 4.04, "displayName": "Esperion Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]